Cargando…
Oxaliplatin-induced haematological toxicity and splenomegaly in mice
PURPOSE: Haematological toxicities occur in patients receiving oxaliplatin. Mild anaemia (grade 1–2) is a common side effect and approximately 90% of recipients develop measurable spleen enlargement. Although generally asymptomatic, oxaliplatin-induced splenomegaly is independently associated with c...
Autores principales: | Lees, Justin G., White, Daniel, Keating, Brooke A., Barkl-Luke, Mallory E., Makker, Preet G. S., Goldstein, David, Moalem-Taylor, Gila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467301/ https://www.ncbi.nlm.nih.gov/pubmed/32877416 http://dx.doi.org/10.1371/journal.pone.0238164 |
Ejemplares similares
-
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2016) -
Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
por: Lowy, Daniel B., et al.
Publicado: (2021) -
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
por: Makker, Preet G. S., et al.
Publicado: (2017) -
Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2019) -
A case of pancytopenia and splenomegaly: haematological disease?
por: Perciaccante, A., et al.
Publicado: (2007)